What is Basaglar?
Basaglar (Insulin Glargine) is a long-acting insulin analog used in the treatment of type 1 diabetes and type 2 diabetes. It provides a basal level of insulin that helps control glucose levels between meals and during sleep, with a duration of action lasting up to 24 hours. Basaglar works by mimicking the body’s natural insulin production, helping to lower blood sugar levels and prevent complications associated with high glucose levels.
What is Basaglar used for?
Basaglar is an insulin preparation that contains etanercept biosimilar, also known as insulin glargine injection, and pegylated human insulin. It is designed to mimic the structure of insulin glargine and human insulin, making it a biosimilar version of the popular diabetes medication. As such, Basaglar works by providing an extended period of glucose control through the stimulation of muscle cells to take up sugar from the blood.
In diabetes management, Basaglar helps maintain normal blood sugar levels in patients with type 2 diabetes mellitus. By injecting insulin glargine and pegylated human insulin, the medication effectively lowers the blood glucose levels without causing significant fluctuations or spikes after injection. Basaglar has been shown to be safe and effective for use as a once-daily injectable in controlling elevated blood sugar levels.
The mechanism of action of Basaglar involves combining insulin glargine and pegylated human insulin, providing sustained glucose-lowering effect through continuous stimulation of peripheral tissue uptake of glucose, while reducing or eliminating hyperglycemia. Studies have demonstrated the effectiveness and safety of Basaglar for use in various patient populations with type 2 diabetes.
Basaglar side effects
Potential Side Effects:
- Injection site reactions (pain, redness, swelling)
- Hypoglycemia (low blood sugar)
- Upper respiratory tract infections
- Nausea and vomiting
- Diarrhea
- Headache
- Dizziness
- Increased risk of infection (including upper respiratory tract infections)
- Increased risk of bladder cancer in people who have a history of radiation therapy to the pelvis or those with other risk factors for bladder cancer
- Changes in blood test results (elevated liver enzymes, increased bilirubin)
- Muscle and back pain
- Rash
- Cough
- Fatigue
- Weight gain
- Increased urination frequency
- Abdominal pain
- Decreased appetite
- Injection site reactions resulting in abscesses or necrosis
Disclaimer
The content on this website is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The information provided here is based on general research and may not apply to individual circumstances. We do not guarantee the accuracy or completeness of any content on this website. Always consult with a healthcare professional before making any changes to your medication or health routine.